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Background: The effect of a weekend compared with a weekday hospital admission in on patient outcomes after an acute coronary syndrome is conflicting. This study aims to determine if collectively there is a weekend effect in acute coronary syndrome.
Method: We conducted a systematic review and meta-analysis of cohort studies examining the association between weekend compared to weekday admission at any time of the day and early mortality (in-hospital or 30-day).  A search was performed on Medline and Embase and relevant studies were pooled using random effects meta-analysis for risk of early mortality.  Additional analyses were performed considering only more recent studies (conducted after 2005) and by patient group (STEMI or NSTEMI) as well as meta-regression according to starting year and mean year of study.
Results: A total of 18 studies were included with over 14 million participants incorporating 3 million weekend and over 11.5 million weekday admissions and the rates of mortality were 19.2% and 23.4%, respectively.  The pooled results of all 18 studies suggest that weekend admission was associated with a small increased risk of early mortality (OR 1.06 95%CI 1.03-1.09).  The results for subgroups of STEMI and NSTEMI cohorts were not statistically significant and timing of admission after 2005 had minimal influence on the results (OR 1.08 95%CI 0.95-1.24).




A weekend effect where outcomes for patients admitted acutely during the weekend are worse than those for patients admitted during the week has been reported in many specialities across medicine1-3 although the cause is unclear.4 On weekends, levels of staffing and access to diagnostics are recognized to be significantly lower than on weekdays.5 In addition, part of the weekend effect may potentially be a selection bias where cohorts admitted at the weekend may be sicker or older compared to those admitted on weekdays.6 This topic is of considerable importance because it is integral to the development of a 7 day NHS (National Health Service) service.7
In one of the first studies to investigate the weekend phenomenon in acute myocardial infarction (AMI), weekend versus weekday admission in over 3 million emergency department admissions in Canada found no significant difference in mortality rates.1 However, a subsequent US study of nearly 60,000 admissions reported a significant increase in 30-day mortality for AMI admissions on the weekend which was mainly driven by the availability of invasive cardiac procedures.8 Since these early studies, many studies have been published9-14 with inconsistent results. Furthermore, since the initial reports of a weekend effect in AMI, there have been significant improvements in the management of AMI with a move towards invasive revascularisation strategies that are not restricted to working hours, as well as advances in pharmacotherapy that may attenuate the weekend effect in more contemporary practice and technologies such as better monitoring through the availability of remote telemetry.




We selected parallel group observational studies that evaluated mortality events among patients admitted with a diagnosis of acute coronary syndrome (NSTEMI, STEMI and unstable angina).  The study had to evaluate day of admission and mortality outcomes for patients admitted on weekend and weekdays.  There was no restriction on whether studies were retrospective or prospective design.  We excluded conference abstracts, letters and studies that used case-control design because incidence rates of mortality cannot be determined for such study designs. 
Search strategy
	We searched MEDLINE and EMBASE using OVID in August 2016 using the search terms as follows: (“weekend” OR “weekday”) AND (“myocardial infarction” OR “STEMI” OR “NSTEMI” OR “acute coronary syndrome”).  We also checked the bibliographies of included studies and relevant reviews for additional studies.
Study selection and data extraction
	Two reviewers (CSK and MA) independently and in duplicate assessed the titles and abstracts of the search results and excluded studies that were clearly not relevant.  Full-text of potentially relevant studies were retrieved and detailed evaluation was performed against the eligibility criteria.  Any uncertainties about inclusion were resolved by consensus through discussion with other co-authors after full review of the manuscript.  Where the same cohort was reported more than once we included the studies that reported the most complete results or had the longest follow up or largest number of participants.  The primary outcome was in-hospital mortality and 30-day mortality was extracted when this was not available.  The reason for this is that early events are more likely to be related to day of admission and as time progresses changes in outcomes may be more related to the care received post admission rather than day of admission.  Secondary outcomes of interest included reinfarction or myocardial infarction, major adverse cardiovascular events by any definition, major bleeding complications and stent thrombosis.
Study characteristics and quality assessment
	Two reviewers (CSK and MA) independently extracted data on study characteristics.  We recorded data on study design, total number of participants, mean age, % of male participants, participant inclusion criteria, type of participants, timing of mortality follow up and results.  Both crude event rates and most adjusted results were extracted.
	Quality assessment was performed by using the Ottawa Newcastle Scale.17  The areas evaluated were representativeness of the weekend cohort, selection of the weekday cohort, ascertainment of weekend/week day admission, comparability of the cohort, appropriate length of follow up and adequacy of follow up.  Funnel plots were used to evaluated publication bias if the analysis had more than 10 included studies and no evidence of statistical heterogeneity.18
Data synthesis
	We used RevMan 5.3 (The Nordic Cochrane Centre) to conduct random-effects meta-analysis for the pooled relative risks (RR), with 95% confidence intervals based on the inverse variance method.  Statistical heterogeneity was assessed using the I2 statistic where 30-60% represent a moderate level of heterogeneity.19 We performed sensitivity analysis by systematically exclusing one study and investigating its effect on statistical heterogeneity where there were sufficient studies (more than 10 studies) in a single analysis. The main analysis was stratified according to whether or not the studies adjusted for potential confounders.  Additional analysis was performed only including studies with STEMI and NSTEMI as well as those which studied cohorts from the past decade (2005 onwards). Further meta-regression was performed on STATA using the metareg function according to starting year of study and mean year of study.
Patient involvement
	Patients were not involved in the design and conduct of the review.

Results
Overview of participant characteristics in the included studies
A total 18 studies met the inclusion criteria as described in Figure 1.1,8-11,20-32 The study design and participant characteristics of the studies included are shown in Table 1.  There were a total of 14,588,798 participants and the mean age across 15 studies, which reported age of the cohort was 65 years and the percentage of male patients was 67% in 17 studies.
Quality assessment in the included studies
The quality assessment of included studies is shown in Supplementary Table 1. The majority of studies evaluated a non-selected ACS cohort for admission on weekend and weekday. Also, most studies used hospital administrative data regarding time of admission and day of admission.  There were inconsistencies in use of adjustments, which varied across the studies but 15 studies used adjustments for potential confounders.  There were reliable methods for mortality assessment across the studies and adequate follow up as the primary outcome was in-hospital mortality or 30-day mortality.  Several studies did however report loss to follow up which was <10%, although this was higher in the studies by Kim et al and Ryan et al which was 45% and 28% respectively.
Characteristics of participants included on weekends compared to weekdays
Supplementary Table 2 shows the characteristics of participants according to weekend and weekday status.  Meta-analysis of each of these characteristics shows that the risk factors of  patients admitted on weekends are were not significantly different although patients admitted on weekends were less likely to have hypertension (OR 0.99 95%CI 0.98-1.00;P=0.02) (Table 2).  Angiography during admission (OR 0.94 95%CI 0.86-1.01, p=0.11, 5 studies) and early or emergency angiography (OR 0.99 95%CI 0.93-1.05, p=0.65, 4 studies) were not significantly less with weekend admission.
Influence of weekend admission on early mortality outcomes
The results of the included studies are shown in Table 5.  There were 3,037,928 participants who were admitted on weekends while 11,550,870 were admitted on weekdays.  14 out of the 18 studies reported crude mortality event rates, which were greater in the weekday group compared to weekend group (weekday 22,303/116,339, 19.2% vs weekend 113,212/483,687, 23.4%).  The pooled results of all 18 studies suggest that patients admitted on the weekend have a small increase in the risk of early mortality compared to patients admitted during the week (OR 1.06 95%CI 1.03-1.09, I2=55%); Figure 2.  Among studies that adjusted for differences in covariates, there was the same weekend effect (OR 1.06 95% CI 1.03-1.09) but this was not statistically significant in studies that did not adjust for differences in covariates (OR 1.10 95% CI 0.88-1.37).
Senstivity analysis exclusing single studies found that exclusion of the study Isogai 2015 reduced statstiscal heterogeneity to I2=39% in the adjusted analysis, and I2=40% overall.  The study by Isogai et al took place in Japan and had the oldest average age for participants among the included studies.  In addition, its methodology differed from the other studies because they excluded patients who were discharged alive on the day of admission and this alters the risk profile of the cohort.
The results for analysis according to the type of acute coronary syndrome are shown in Figure 3.  Among both STEMI and NSTEMI patients, weekend admission was associated with no significant difference in mortality (OR 1.04 95%CI 1.00-1.08 for STEMI and OR 1.12 95%CI 0.98-1.28 for NSTEMI) Further sensitivity analyses restricting the studies that were conducted after 2005 (Supplementary Table 1) showed a statistically significant weekend effect for early mortality among studies undertaken prior to 2005 but not for those after 2005, although OR were similar in magnitude.  Meta-regression according to starting year (Supplementary Figure 1a) and mean year (Supplementary Figure 1b) showed a significant relationship between year of study and early mortality (p=0.019 and p=0.025, respectively).
	The pooled results for difference in other adverse outcomes with weekend compared to weekday admission are shown in Figure 4.  The results suggest that there is no significant difference in re-infarction (OR 1.06 95%CI 0.85-1.33), major adverse cardiovascular events (OR 1.08 95%CI 0.97-1.21) and major bleeding (OR 0.75 95%CI 0.50-1.12) with weekend compared to weekday admission.

Discussion
Our results suggest a small weekend effect where patients with ACS admitted on weekends have worse mortality outcomes compared to weekday admissions (OR 1.06 95% CI 1.03-1.09).  This effect was no longer statistically significant when restricting analysis to the fewer studies undertaken in the past decade, but the estimate was similar in magnitude to the main analysis (OR 1.08 95% CI 0.96-1.21). Furthermore no significant differences for participants with STEMI and NSTEMI were observed. The mechanisms that underlie this 6% difference in early mortality among weekend admissions remains unclear.  
Selection bias has been proposed as one potential mechanism for the weekend effect.11  It is possible that more severely ill patients are admitted to hospital on weekends while patients with less severe presentations wait intentionally for weekday assessment.33 However our sensitivity analysis did not find significant differences in age or comorbidities in patient groups presenting at the weekend versus weekday. The effect of more severe presentations of AMI has been explored by Isogai et al who found that weekend admission was associated with increased mortality in Killip class II to IV but not Killip class I.10 They further suggest that while invasive procedures are available on weekends in their study, there may still be reduced staff sufficient to provide a level of care to rescue patients with AMI who rapidly progress to unfavourable outcomes.10
It has also been suggested that differences in staff related issues in delivering of care in hospitals on weekends may account for the disparity of outcomes amongst weekend admissions, although more recent literature would argue against this.  Possible reasons for worse outcomes on weekend admissions include reduced overall staffing, the presence of less senior doctors and less experienced staff, the need for cross-cover of other clinician’s patients, loss of continuity of care, and less supervision of junior staff.1 The reduced availability of senior staff is supported by a survey of over 30,000 clinicians that found that emergency admissions to English hospitals on a Sunday receive less input from specialists compared to the Wednesday.34  Furthermore, in terms of staffing levels on Sunday, no hospital in England has achieved 50% of the staffing levels on Wednesday.   In contrast, in a study of Gulf countries where they employ many expatriate staff who are senior level and experienced to work weekend and after hours, no weekend effect was observed.21
Another potential reason relates to availability of diagnostic and therapeutic procedures.  Studies have consistently shown that timeliness of revascularization is a major prognostic factor in patients with STEMI35 so current guidelines recommend 90-minute window for door-to-balloon time.  A key consideration in the debate regarding the weekend effect is the possible difference in door-to-balloon time for STEMI patients where delays in revascularization are highly correlated to poor outcome. However, in NSTEMI, the optimal timing for invasive angiography is less clear.37-39 Studies have shown that weekend admission are less likely to undergo angiography compared to weekdays.8,40 The study by Gyenes et al suggest that patients admitted on weekends are less likely to be admitted to a hospital with on-site angiography (26.8% for weekend admissions compared to 29.9% on weekday admissions).23  In the current study, we found no significant difference in receipt of angiography during the admission and early/emergency angiography between the weekend and weekday groups.

We have built on the findings of a previous review by Sorita et al who evaluated the effect of out-of-hours presentation AMI and adverse outcomes.16 We included studies published since that review and similarly observed that patients admitted on weekends have higher mortality compared to those which present on weekdays.  Restricting our analysis to more recent studies and those of specific indications like STEMI and NSTEMI did show significant differences overall but it was only of borderline statistical significance amongst adjusted studies.  We were able to perform more in-depth analysis by undertaking sensitivity analyses to study differences in characteristics for participants who were admitted on weekends compared to weekdays.  Surprisingly we did not find any difference in either age or comorbidity for patients admitted on weekends, however these results were only based on crude data.  We were also able to build on the mortality findings that have only been reported previously, by studying other endpoints and showing no significant differences in adverse outcomes including re-infarction, MACE, major bleeding and stent thrombosis.
It is interesting to see that the weekend effect whilst not statistically significant when restricted to studies published in the last decade, is of a similar magnitude to the main analysis (OR 1.08 vs 1.06). The persistence of this small weekend effect is surprising, as a weekend effect may have been more evident historically where ACS services may not have been configured to offer invasive therapies to unstable NSTEMI or cases where thrombolysis had failed during the weekend. ACS services have become reconfigured over time so that there is more senior input on weekends including 24 hours a day 7 days a week emergency PCI for primary PCI and unstable NSTEMI cases and one may have expected this to contribute to a reduction in any weekend effect over time, which we have not observed. 
Furthermore, public health initiatives have been implanted and patients probably recognize the importance of early presentation to emergency services during episodes of chest pain. Khoshchehreh et al have reported that weekend rates of NSTEMI have increased from 19% to 23% between 2001 and 2011 while weekend STEMI rates increased from 25% to 29% in 2011.11  There may also be scope for improvements in out-of-hospital cardiac arrest care during off-hours as one study suggests that survival rates are 30% lower compared to those arrests during regular hours.41Our study has several strengths and limitations.  Firstly the sample size is large with over 14 million participants.  In addition, we included abstracts that would reduce the risk of publication bias.  We were also able to consider patients with STEMI and NSTEMI separately and study the effect of the year in which studies were started or conducted.  Our study was limited because were unable to comment on the cause of death, whether they were cardiovascular or non-cardiovascular related mortality. Another limitation is that our study is not an individual patient meta-analysis and the results presented are limited to those already reported in published literature.  There is also significant heterogeneity in the studies that may reflect differences in the populations in the included studies.  As with any observational study there are always risk of bias from unmeasured confounders. 
The importance of determining the effect on patient outcomes of reduced staffing at weekends is topical for all healthcare systems. Through studying its effect on many different clinical presentations, it may be possible to improve outcomes through either increasing healthcare resources or redistributing existing resources from specialities with no discernible weekend effect to those with. Our study, looking at ACS presentation suggests that patients admitted during the weekend are at increased risk of early mortality, although it is uncertain if investing precious healthcare resource on weekend care will actually improve patient outcomes. 
In conclusion, existing literature suggests that patients with heart attacks who are admitted on weekends have a small increase in risk of mortality at 30 days compared to those admitted on weekdays. 
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Table 1: Study design and participant characteristics.

Study ID	Study design; Country; Year	No. of participants	Mean age	% Male	Participant inclusion criteria
Al-Asdi 2014	Retrospective cohort study; Iraq; 2012.	419	62.4	64.9	Participants had AMI and were admitted to cardiac care unit.
Al-Lawati 2012	Prospective cohort study; Middle Eastern Countries; 2008-2009.	4,616	59.6	72.2	Participants were in Gulf RACE 2 multicentre registry with ACS.
Bell 2001	Cohort study; Canada; 1988-1997.	160,220	-	50.3 (full cohort)	Participants were admitted to hospital and only admission with myocardial infarction were included. 
Clarke 2010	Retrospective cohort study; Australia; 2002-2007.	17,910	-	62.4	Participants with AMI.
Gyenes 2013	Prospective cohort study; Canada; 1999-2008.	6,711	68	66.3	Participants had NSTEMI in the Canadian GRACE/GRACE2/CANRACE program.
Hansen 2013	Cohort study; Denmark; 1997-2009.	101,948	68.6	63.1	Participants had AMI in the Danish National Patient Registry.
Hong 2010	Cohort study; South Korea; 2003-2007.	97,466	64.6	62.2	Participants with AMI in the Korea National Health Insurance Claims Database of the Health Insurance Review and Assessment Service.
Isogai 2015	Retrospective cohort study; Japan; 2010-2013.	111,200	69.5	71.6	Participants with AMI in Japan in the Diagnosis Procedure Combination inpatient database.
Khoshchehreh 2016	Retrospective cohort study; USA; 2001-2011.	13,988,772	65.8	58.2	Participants with ACS in the US Nationwide Inpatient Sample database.
Kim 2015	Retrospective cohort study; South Korea; 2007-2010.	577	63.7	71.4	Participants with NSTEMI and unstable angina and PCI.
Kostis 2007	Cohort study; USA; 1987-2002.	231,164	68.1	59.7	Participants with AMI.
Kruth 2008	Prospective cohort study; Germany; 1994-2002.	11,516	65	70.5	Participants were in the MITRA-PLUS multicenter registry of ACS patients.
Lairez 2009	Prospective cohort study; France; 2005-2008.	2,266	64.8	77.3	Participants with emergency PCI.
Matsui 2007	Retrospective cohort study; Japan; 2000-2003.	4,805	68.0	70.8	Participants with AMI in the Japanese Acute Coronary Syndrome Study.
O’Neill 2014	Cohort study; Canada; 2005-2010.	11,981	65.1	69.2	Participants with NSTEMI in the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease.
Rosende 2015	Retrospective cohort study; Argentina; Unclear.	10,514	60.6	76.1	Participants with ACS in the Epi-Cardio Registry.
Ryan 2005	Cohort study; USA; 2001-2003.	56,352	67	60.8	Participants with unstable angina and NSTEMI in CRUSADE registry.
Turin 2009	Cohort study; Japan; 1988-2003.	379	-	64.6	Participants with AMI in the Takashima AMI Registry.







Table 2: Meta-analysis of factors associated with weekend admission
Variable	No. of studies	Effect estimate (mean difference or odds ratio) 95% CI	p-value
Age	7	-0.05 (-0.53 - 0.44)	0.85
Female gender	16	1.00 (0.97 - 1.02)	0.76
Smoker	8	0.97 (0.93 - 1.01)	0.15
Diabetes	14	1.17 (0.78 - 1.75)	0.45
Hypertension	12	0.99 (0.98 - 1.00)	0.02
Prior MI	9	1.03 (0.99 - 1.08)	0.19
Prior stroke	8	1.00 (0.95 - 1.05)	0.96
Renal failure	10	1.03 (0.94 - 1.13)	0.56
Anemia	3	1.00 (0.92 - 1.09)	0.99
Heart failure	7	0.59 (0.33 - 1.05)	0.07
Hyperlipidemia	7	0.98 (0.95 - 1.02)	0.37
STEMI	3	1.07 (0.99 - 1.16)	0.10
Prior PCI	3	0.97 (0.91 - 1.03)	0.27
Prior CABG	6	0.99 (0.92 - 1.05)	0.65
Cancer	4	0.98 (0.91 - 1.05)	0.50
Cardiogenic shock	3	1.08 (1.00 - 1.16)	0.06
COPD	3	1.04 (0.98 - 1.11)	0.18
Rural, remote or non-urban admission	3	1.08 (0.96 - 1.21)	0.22
Caucasian race	3	1.00 (0.98 - 1.01)	0.49
Aspirin	5	1.00 (1.00 - 1.00)	0.34
Clopidogrel	5	0.97 (0.94 - 1.00)	0.09
Beta-blocker	5	1.00 (1.00 - 1.01)	0.36
ACEi/ARB	4	0.95 (0.77 - 1.17)	0.66
Statin	4	1.00 (0.97 - 1.02)	0.92
Heparin	3	1.01 (0.95 - 1.08)	0.67
Angiography during admission	5	0.94 (0.86 - 1.01)	0.11





Table 3: Outcomes evaluated and results.
Study ID	Diagnosis	No. in weekend group	No. in weekday group	Results and follow up
Al-Asdi 2014	AMI	36/154	33/265	In-hospital mortality: aOR: 0.658 (0.311-1.392).
Al-Lawati 2012	ACS	101/1,102	358/3,514	30-day mortality: aOR 0.88 (0.68-1.14).
Bell 2001	AMI	15%	15%	In-hospital mortality: aOR 1.03 (1.00-1.06).
Clarke 2010	AMI	541/4,848	1,249/13,062	In-hospital mortality: aRR 1.15 (1.03-1.26).
Gyenes 2013	NSTEMI	63/1,956	140/4,755	In-hospital mortality: aOR 1.52 (1.15-2.01).
Hansen 2013	AMI	3,801/9,732	25,451/66,718	30-day mortality: 1997-1999 aHR 1.06 (0.99-1.13), 2000-2002 aHR 0.99 (0.93-1.07), 2003-2005 aHR 0.99 (0.92-1.07), 2006-2009 aHR 1.08 (0.99-1.18).
Hong 2010	AMI	5,158/25,663	12,421/71,803	30-day mortality: aOR 1.05 (0.99-1.11).
Isogai 2015	AMI	4,182/30,847	9,140/80,353	In-hospital mortality: aOR 1.144 (1.079-1.214).
Khoshchehreh 2016	STEMI/NSTEMI	STEMI: 523,612. NSTEMI: 2,397,977.	STEMI: 1,447,583. NSTEMI: 9,619,600.	In-hospital mortality: STEMI aOR 1.03 (1.01-1.04), NSTEMI aOR 1.15 (1.14-1.16).
Kim 2015	NSTEMI	5/168	2/409	Crude results for 30-day cardiac mortality.
Kostis 2007	AMI	7,245/19,497	61,152/170,012	In-hospital mortality: 1987-1990 aHR 1.034 (1.009-1.059), 1991-1994 aHR 1.025 (0.997-1.054), 1995-1998 aHR 1.015 (0.986-1.045), 1999-2002 aHR 1.055 (1.024-1.086).
Kruth 2008	STEMI	457/4,115	739/7,401	Crude results for in-hospital mortality.
Lairez 2009	PCI	-	-	In-hospital mortality: weekend daytime vs weekday daytime aOR 2.42 (0.97-6.01).
Matsui 2007	AMI	120/1,279	307/3,526	Mortality: aHR 1.066 (0.797-1.427).
O’Neill 2014	NSTEMI	56/3,848	117/8,133	In-hospital mortality: aHR 0.95 (0.69-1.32).
Rosende 2015	STEMI/NSTEMI	STEMI: 51/1,048. NSTEMI: 17/1,278.	STEMI: 152/3,189. NSTEMI: 84/4,999.	Crude results for in-hospital mortality.
Ryan 2005	NSTEMI/UA	475/10,804	1,867/45,548	In-hospital mortality: NSTEMI/UA: aOR 1.02 (0.92-1.13). NSTEMI: aOR 1.03 (0.93-1.15).
Turin 2009	AMI	-	-	28-day mortality: aHR 1.07 (0.5-2.1).
AMI=acute myocardial infarction; ACS=acute coronary syndrome; NSTEMI=non-ST-elevated myocardial infarction; STEMI=ST-elevated myocardial infarction; UA=unstable angina.


Table 4: Sensitivity analysis according to studies conducted before or after 2005

Analysis by starting year	No. of studies	OR [95%CI]
Adjusted after 2005	6	1.06 [0.95, 1.17]
Adjusted prior to 2005	11	1.05 [1.02, 1.07]
Unadjusted after 2005	3	1.30 [0.89, 1.90]
Unadjusted prior to 2005	3	1.04 [0.97, 1.12]
Analysis by mean year	No. of studies	OR [95%CI]
Adjusted after 2005	9	1.05 [0.98, 1.12]
Adjusted prior to 2005	8	1.05 [1.02, 1.07]
Unadjusted after 2005	4	1.13 [0.93, 1.37]










Figure 2: Risk of mortality with weekend versus weekday admission.

Figure 3: Risk of mortality with weekend versus weekday admission by indication.






Supplementary Table 1: Quality assessment of included studies.






Gyenes 2013	*	*	*	*	*	*	* (<1% missing data).
Hansen 2013	*	*	*	*	*	*	*
Hong 2010	*	*	*	*	*	*	*
Isogai 2015	*	*	*	*	*	*	* (<1% excluded for same day discharge).
Khoshchehreh 2016	*	*	*	*	*	*	*
Kim 2015	*	*	*		*	*	45% were excluded because they were not admitted to CCU.
Kostis 2007	*	*	*	*	*	*	* (<3% excluded).
Kruth 2008	*	*	*		*	*	*









Supplementary Table 2: Patient characteristics and other factors according to weekend or weekend admission
Study ID	Variable	Weekend group	Weekday group	Multivariate risk estimate (95% CI)	p-value
Al-Asdi 2014	AgeFemaleSmokerDiabetesHypertensionPrevious MISTEMIPre-hospital delay >12hSBPDBP	63.4±11.357/154 (27%)47/154 (30.5%)59/154 (38.3%)93/154 (60.4%)75/154 (35.7%)107/154 (69.5%)62/154 (40.3%)127.1±36.278.3±22.2	61.8±11.890/265 (34%)75/265 (28.3%)97/265 (36.6%)136/265 (51.3%)125/265 (47.2%)152/265 (57.4%)124/265 (46.8%)135.3±35.982.9±21.7	----------	0.1560.5280.8900.7270.0720.7620.0140.1940.0250.037
Al-Lawati 2012	AgeFemaleCurrent smokersDiabetes mellitusHypertensionAnemiaRenal diseasesCerebrovascular accidentMyocardial infarctionCongestive heart failureValvular heart diseasePCICABGSTEMINon-STEMIUnstable anginaAnteriorInferiorLateralOther siteAspirinClopidogrelB-blockersACEI/ARBStatinsHeparinMechanicalArrhythmicRe-infarctMajor bleedAngiographyPCICABGLength of stayDoor-to-needle ≤30 min (%)Door-to-balloon time ≤90 min (%) 	59.5±12.0302/1,102 (27.4%)325/1,102 (29.5%)460/1,102 (41.7%) 547/1,102 (49.6%)389/1,102 (35.3%)64/1,102 (5.8%)71/1,102 (6.4%)236/1,102 (21.4%)83/1,102 (7.5%)15/1,102 (1.4%)108/1,102 (9.8%)54/1,102 (4.9%)456/1,102 (41.4%)358/1,102 (32.5%)287/1,102 (26.0%)615/1,102 (55.8%)449/1,102 (40.7%)36/1,102 (3.3%)3/1,102 (0.23%)1,084/1,102 (98.4%)789/1,102 (71.6%)791/1,102 (71.8%)847/1,102 (76.9%)1,040/1,102 (94.4%)868/1,102 (78.8%)219/1,102 (19.9%)69/1,102 (6.3%)33/1,102 (3.0%)8/1,102 (0.7%)293/1,102 (26.6%)150/1,102 (13.6%)19/1,102 (1.7%)6.127.753.3	59.6±12.7980/3,514 (27.9%)998/3,514 (28.4%)1,462/3,514 (41.6%)1,764/3,514 (50.2%)1,170/3,514 (33.3%)172/3,514 (4.9%)179/3,514 (5.1%)794/3,514 (22.6%)299/3,514 (8.5%)70/3,514 (2.0%)369/3,514 (10.5%)172/3,514 (4.9%)1,367/3,514 (38.9%)1,110/3,514 (31.6%)1,037/3,514 (29.5%)2,115/3,514 (60.2%)1,304/3,514 (37.1%)88/3,514 (2.5%)8/3,514 (0.23%)3,451/3,514 (98.2%)2,513/3,514 (71.5%)2,523/3,514 (71.8%)2,660/3,514 (75.7%)3,303/3,514 (94.0%)2,758/3,514 (78.5%)678/3,514 (19.3%)257/3,514 (7.3%)91/3,514 (2.6%)25/3,514 (0.7%)1,089/3,514 (31.0%)488/3,514 (13.9%)112/3,514 (3.2%)6.432.151.6	------------------------------OR 0.77 (0.62-0.95)-----	0.710.740.490.950.740.220.260.080.390.300.270.490.940.140.570.020.420.680.560.950.450.670.870.690.250.530.960.0060.820.010.240.250.87
Bell 2001	Female Arrival by ambulanceAdmitted to teaching hospitalCharlson score for comorbidity >2Underwent surgery	499,770/1,005,573 (49.7%)336,867/1,005,573 (33.5%)190,053/1,005,573 (18.9%)52,290/1,005,573 (5.2%)175,975/1,005,573 (17.5%)	1,406,094/2,784,344 (50.5%)871,500/2,784,344 (31.3%)545,731/2,784,344 (19.6%)153,139/2,784,344 (5.5%)509,535/2,784,344 (18.3%)	------	------
Clarke 2010	Age ≥75 yearsFemaleIndigenousMost disadvantaged socioeconomic statusRemoteVentilation receivedAcute respiratory failureChronic renal failureDementiaDiabetesHeart failureHypertensionIschaemic heart diseasePneumoniaStroke	2,050/4,848 (42.3%)1,827/4,848 (37.7%)197/4,848 (4.1%)563/4,848 (11.6%)139/4,848 (2.9%)195/4,848 (4.0%)15/4,848 (<1.0%)472/4,848 (9.7%)181/4,848 (3.7%)1,197/4,848 (24.7%)1,034/4,848 (21.3%)2,065/4,848 (42.6%)1,957/4,848 (40.4%)151/4,848 (3.1%)140/4,848 (2.9%) 	5,394/13,0624,916/13,062 (37.6%)541/13,0621,442/13,062340/13,062472/13,06248/13,0621,212/13,062463/13,0623,290/13,0622,585/13,0625,677/13,0625,243/13,062368/13,062376/13,062	---------------	---------------
Gyenes 2013	AgeFemaleMICHFPrevious PCIPrevious CABGPeripheral arterial diseaseHypertensionDyslipidemiaTIA and/or strokeDiabetes mellitusSmokerSymptom onset to hospital presentation/admission Admitted to hospitals with on-site coronary angiographySystolic blood pressurePulseKillip class III/IVCardiac arrest on presentationST deviationInitial cardiac biomarker elevationInitial creatinineGRACE risk score	67 (57-78)671/1,956 (34.3%)643/1,956 (33.1%)231/1,956 (11.9%)279/1,956 (14.4%)250/1,956 (12.9%)183/1,956 (9.4%)1,209/1,956 (62.1%)1,029/1,956 (53%)180/1,956 (9.3%)581/1,956 (30%)995/1,956 (51.3%)2.8 (1.3-6.8)453/1,956 (26.8%)145 (127-166)82 (69, 97)134/1,95622/1,956 (1.2%)690/1,956 (35.3%)1,266/1,956 (65%)94 (80-118)129 (102, 161)	68 (58-78)1,586/4,755 (33.4%)1,528/4,755 (32.3%)558/4,755 (11.9%)713/4,755 (15.1%)599/4,755 (12.7%)465/4,755 (9.9%)2,997/4,755 (63.2%)2,536/4,755 (53.8%)504/4,755 (10.7%)1,351/4,755 (28.9%)2,506/4,755 (53.3%)2.8 (1.3-7.0)1,503/4,755 (29.9%)146 (128-164)80 (68, 96)294/4,7551,678/4,755 (35.3%)1,678/4,755 (35.3%)3,235/4,755 (68.2%)94 (78-116)129 (103, 161)	----------------------	0.160.480.570.920.460.840.580.370.550.090.250.150.980.0140.520.030.680.170.99<0.010.120.54
Hansen 2013	AgeFemaleTransfer during admissionCongestive heart failureCardiac dysrhythmiaPulmonary oedemaCardiogenic shockCerebrovascular diseaseCancerCOPDAcute renal failureChronic renal failureDiabetes with complicationsCoronary angiogram Day 2Coronary angiogram Day 30	68.29,264/25,451 (36.4%)4,828/25,451 (19.0%)2,874/25,451 (11.3%)2,747/25,451 (10.8%)248/25,451 (1.0%)179/25,451 (0.7%)1,358/25,451 (5.3%)731/25,451 (2.9%)1,670/25,451 (6.6%)218/25,451 (0.9%)328/25,451 (1.3%)1,133/25,451 (4.5%)4,747/19,492 (24%)10,846/19,492 (56%)	68.724,782/66,718 (37.1%)11,527/66,718 (17.3%)8,025/66,718 (12.0%)7,504/66,718 (11.2%)646/66,718 (1.0%)456/66,718 (0.7%)3,376/66,718 (5.1%)1,810/66,718 (2.7%)4,083/66,718 (6.1%)658/66,718 (1.0%)871/66,718 (1.3%)2,985/66,718 (4.5%)12,895/51,494 (25%)43,634/51,494 (56%)	---------------	---------------
Hong 2010	AgeFemaleLength of stayDiabetesHypertensionCOPDLiver diseaseRenal diseaseCerebrovascular diseaseAnemiaCancerCoronary angiogram on day of admissionCoronary angiogram within 30 days	64.5±13.99,629/25,663 (37.6%)9.9±14.41,649/25,663 (6.4%)6,368/25,663 (24.8%)183/25,663 (0.7%)183/25,663 (0.7%)29/25,663 (0.1%)726/25,663 (2.8%)91/25,663 (0.4%)142/25,663 (0.6%)14,261/25,663 (55.5%)14,787/25663 (57.5%)	64.7±13.627,217/71,803 (37.9%)10.2±16.14,658/71,803 (6.5%)18,445/71,803 (25.7%)603/71,803 (0.8%)457/71,803 (0.6%)93/71,803 (0.1%)1,990/71,803 (2.8%)318/71,803 (0.4%)445/71,803 (0.6%)42,357/71,803 (58.9%)43,634/71,803 (60.8%)	------------	0.0530.2760.0470.7310.0060.2720.1920.5210.6310.0600.238--
Isogai 2015	AgeFemaleAmbulance useKillip class III/IVShockDiabetes with complicationsHeart failureNeoplasmCerebrovascular diseasePulmonary oedemaAcute renal failureChronic renal failureCardiac arrhythmiaAcademic hospitalHospital volume top quartileCoronary angiogram on day of admissionCoronary angiogram during hospitalizationPCIFibrinolytic therapyAny reperfusion therapyIntra-aortic balloon pumpECMOMechanical ventilationRenal replacement therapyPCICABGAspirinClopidogrel/ticlopidineACE-I/ARBΒ-blockerStatin	69.1±13.38,560/30,847 (27.7%)20,462/30,847 (66.3%)7,152/30,847 (23.2%)2,591/30,847 (8.4%)1,966/30,847 (6.4%)9,326/30,847 (30.2%)1,105/30,847 (3.6%)1,176/30,847 (3.8%)125/30,847 (0.4%)440/30,847 (1.4%)1,292/30,847 (4.2%)3,984/30,847 (12.9%)5,708/30,847 (18.5%)8,234/30,847 (26.7%)22,962/30,847 (74.4%)26,840/30,847 (87.0%)21,262/30,847 (68.9%)501/30,847 (1.6%)21,372/30,847 (69.3%)3,472/30,847 (11.3%)517/30,847 (1.7%)3,675/30,847 (11.9%)2,741/30,847 (8.9%)24,519/30,847 (79.5%)605/30,847 (2.0%)26,853/30,847 (87.1%)24,414/30,847 (68.1%)21,013/30,847 (79.1%)16,522/30,847 (53.6%)21,645/30,847 (70.2%)	69.7±69.723,057/80,353 (28.7%)45,643/80,353 (56.3%)16,270/80,353 (20.3%)6,034/80,353 (7.5%)5,553/80,353 (6.9%)24,095/80,353 (30%)3,129/80,353 (3.9%)3,180/80,353 (4.0%)256/80,353 (0.3%)1,107/80,353 (0.3%)3,632/80,353 (4.5%)9,448/80,353 (11.8%)15,094/80,353 (18.8%)19,960/80,353 (24.8%)57,649/80,353 (71.7%)70,649/80,353 (87.6%)62,029/80,353 (77.2%)1,246/80,353 (1.6%)52,305/80,353 (65.1%)8,021/80,353 (10%)1,084/80,353 (1.3%)7,856/80,353 (9.8%)5,902/80,353 (7.3%)62,029/80,353 (77.2%)1,775/80,353 (2.2%)69,770/80,353 (86.8%)62,583/80,353 (77.9%)54,252/80,353 (67.5%)42,843/80,353 (53.3%)56,395/80,353 (70.2%)	------------------------------	<0.0010.002<0.001<0.001<0.0010.0010.4220.0150.2640.0270.5350.016<0.0010.283<0.001<0.001<0.0010.378<0.001<0.001<0.001<0.001<0.001<0.0010.0110.324<0.0010.0540.4680.961
Khoshchehreh 2016	AgeFemaleWhite raceMedicareMedicaidRural hospitalTeaching hospitalSmall hospitalCongestive heart failureCOPDDepressionDiabetesHypertensionFluid and electrolyte disorderMorbid obesityRenal failureValvular diseaseHyperlipidaemiaCardiac procedure after admission	66.2±21.21,263,871/2,921,589 (43.3%)2,268,397/2,921,589 (77.6%)1,645,175/2,921,589 (56.3%)183,102/2,921,589 (6.3%)462,456/2,921,589 (15.8%)1,284,453/2,921,589 (44.0%)318,008/2,921,589 (10.9%)89,926/2,921,589 (3.1%)525,308/2,921,589 (18.0%)169,236/2,921,589 (5.8%)878,296/2,921,589 (30.1%)1,824,462/2,921,589 (62.4%)369,191/2,921,589 (12.6%)269,059/2,921,589 (9.2%)267,064/2,921,589 (9.1%)33,246/2,921,589 (1.1%)1,357,288/2,921,589 (46.5%)976,411/2,921,589 (33.4%)	65.7±20.44,586,252/11,067,183 (41.4%)8,716,971/11,067,183 (78.8%)6,324,105/11,067,183 (57.1%)645,675/11,067,183 (5.8%)1,529,934/11,067,183 (13.8%)4,874,627/11,067,183 (44.0%)1,132,645/11,067,183 (10.2%)351,470/11,067,183 (3.2%)1,850,294/11,067,183 (16.7%)652,787/11,067,183 (5.9%)3,368,792/11,067,183 (30.4%)6,966,532/11,067,183 (62.9%)1,048,865/11,067,183 (9.5%)1,031,569/11,067,183 (9.3%)844,740/11,067,183 (7.6%)110,210/11,067,183 (1.0%)5,512,466/11,067,183 (49.8%)4,234,830/11,067,183 (38.3%)	-------------------	------------------
Kim 2015	AgeFemaleBody mass indexHypertensionDiabetes mellitusHyperlipidemiaCurrent smokingPrevious MIPrevious CABGHemoglobineGFRTotal cholesterolNT-proBNPhSCRPCK-MB elevationTroponin-I elevationST depressionT-wave inversionLVEFTIMI risk score (5-7)Culprit arteryLeft mainLADLeft circumflexRCAMultivessel diseaseHeparinGlycoprotein IIb/IIIa inhibitorAspirinClopidogrelβ-blockerACEi/ARBDHP CCBNon DHP CCBNitrateStatin	63.3±13.1123/168 (73.2%)24.5107/168 (63.7%)53/168 (31.5%)55/168 (32.7%)65/168 (38.7%)24/168 (14.3%)6/168 (3.6%)13.967.7190.12,117.91.2973/168 (43.5%)119/168 (70.8%)59/168 (35.1%)38/168 (22.6%)55.224/168 (14.3%)5 (3.0%)84/168 (49.4%)43/168 (25.6%)37/168 (22.0%)109/168 (64.9%)163/168 (97.0%)38/168 (22.6%)168/168 (100.0%)
168/168 (100.0%)111/168 (66.1%)134/168 (79.8%)24/168 (14.3%)12/168 (7.1%)26/168 (15.5%)150/168 (83.3%)	64.0±12.6289/409 (70.7%)24.2251/409 (61.4%)133/409 (32.5%)116/409 (28.4%)128/409 (31.3%)58/409 (14.2%)10/409 (2.4%)13.865.3190.92,356.30.99135/409 (33.0%)231/409 (56.5%)110/409 (26.9%)56.245/409 (11.0%)14/409 (3.4%)206/409 (50.6%)94/409 (23.0%)92/409 (22.5%)270/409 (66.0%)368/409 (90.0%)79/409 (19.3%)409/409 (100.0%)409/409 (100.0%)261/409 (63.8%)300/409 (73.5%)55/409 (13.4%)24/409 (5.9%)71/409 (17.4%)334/409 (81.9%)	-----------------------------------	0.5860.5370.3820.6020.8210.2960.0870.9740.4540.6880.3820.8480.6950.2550.0180.0010.3620.8640.0050.3701.000
1.0000.6330.7910.5730.6260.720
Kostis 2007	AgeFemaleWhite raceAnteriorInferiorLateralOther siteQ-waveDiabetesHypertensionRenal diseaseLiver diseaseAnemiaCancerCerebrovascular disease	67.824,331/61,152 (39.8%)51,970/61,152 (85.0%)15,174/61,152 (24.8%)18,604/61,152 (30.4%)1,419/61,152 (2.3%)5,220/61,152 (8.5%)35,243/61,152 (57.6%)15,611/61,152 (25.5%)27,103/61,152 (44.3%)3,369/61,152 (5.5%)215/61,152 (0.4%)6,319/61,152 (10.3%)1,531/61,152 (2.5%)3,057/61,152 (5.0%)	68.268,938/170,012 (40.5%)144,320/170,012 (84.9%)42,151/170,012 (24.8%)50,725/170,012 (29.8%)3,938/170,012 (2.3%)14,891/170,012 (8.8%)86,768/170,012 (56.9%)43,917/170,012 (25.8%)76,828/170,012 (45.2%)9,269/170,012 (5.4%)595/170,012 (0.4%)17,474/170,012 (10.3%)4,271/170,012 (2.5%)8,792/170,012 (5.2%)	-------------	-------------
Kruth 2008	AgeFemaleHistory of MIHistory of PCI or CABGDiabetes mellitusHistory of stroke/TIAPeripheral artery diseaseCurrent smokerHyperlipidemiaHypertensionObesityRenal failureAnterior MIAtrial fibrillationLeft bundle branch blockHeart rate >100 beats/minCardiogenic shockTIMI risk score for STEMIPrimary PCIFibrinolysisAspirinClopidogrelStatinβ-blockerACE inhibitor	65.2 (56.2-73.7)1,177/4,115 (28.6%)753/4,115 (18.3%)457/4,115 (11.1%)1,000/4,115 (24.3%)
156/4,115 (3.8%)280/4,115 (6.8%)1,494/4,115 (36.3%)1,901/4,115 (46.2%)2,062/4,115 (50.1%)881/4,115 (21.4%)132/4,115 (3.2%)1,959/4,115 (47.6%)255/4,115 (6.2%)
296/4,115 (7.2%)
790/4,115 (19.2%)317/4,115 (7.7%)3.81,498/4,115 (36.4%)1,370/4,115 (33.3%)3,852/4,115 (93.6%)2,329/4,115 (56.6%)2,597/4,115 (63.1%)2,983/4,115 (72.5%)2,601/4,115 (63.2%)	65.3 (55.9-73.9)2,224/7,401 (30.1%)1,179/7,401 (15.9%)819/7,401 (11.1%)1,658/7,401 (22.4%)260/7,401 (3.5%)449/7,401 (6.1%)2,738/7,401 (37.0%)3,552/7,401 (48.0%)3,782/7,401 (51.1%)1,551/7,401 (21.0%)222/7,401 (3.0%)3,554/7,401 (48.0%)437/7,401 (5.9%)512/7,401 (6.9%)1,329/7,401 (18.0%)571/7,401 (7.7%)3.73,257/7,401 (44.0%)2,258/7,401 (30.5%)6,943/7,401 (93.8%)4,524/7,401 (61.1%)4,878/7,401 (65.9%)5,461/7,401 (73.8%)4,700/7,401 (63.5%)	------------------------	------------------------
Lairez 2009	-	-	-	-	-
Matsui 2007	AgeFemaleHypertensionDiabetesHyperlipidemiaBody mass indexCurrent smokerSerum creatininePrevious MIPre-infarct angina pectorisSTEMIKillip class ≥IIQ wave infarctionEmergency coronary angiographyReperfusion therapyPCIStent implantation	67.9±12.0379/1,279 (29.6%)734/1,279 (57.4%)400/1,279 (31.3%)431/1,279 (33.7%)23.5472/1,279 (36.9%)1.06185/1,279 (14.5%)476/1,279 (37.2%)1,140/1,279 (89.1%)266/1,279 (20.8%)926/1,279 (72.4%)1,126/1,279 (88.0%)1,041/1,279 (81.4%)931/1,279 (72.8%)747/1,279 (58.4%)	68.1±12.41,026/3,526 (29.1%)2,024/3,526 (57.4%)1,149/3,526 (32.6%)1,157/3,526 (32.8%)23.61,615/3,526 (45.8%)1.06430/3,526 (12.2%)1,361/3,526 (38.6%)3,071/3,526 (87.1%)666/3,526 (18.9%)2,532/3,526 (71.8%)3,117/3,526 (88.4%)2,874/3,526 (81.5%)2,560/3,526 (72.6%)2,158/3,526 (61.2%)	-----------------	0.7220.7330.9860.4140.5630.1800.5420.9250.0440.3890.0710.1330.6790.7500.9420.9130.091
O’Neill 2014	AgeFemaleHeart failure at presentationPrior PCIPrior CABGPrior MIDiabetesHypertensionHyperlipidemiaCurrent/recent smokerRenal insufficiencyTIMI score>3Non-urban hospitalCatheterizationPCICABG	65.2 (58.7-71.7)1,176/3,848 (30.6%)258/3,848 (6.7%)777/3,848 (20.2%)345/3,848 (9.0%)899/3,848 (23.4%)906/3,848 (23.5%)2,334/3,848 (60.7%)2,686/3,848 (69.8%)1,000/3,848 (26.0%)259/3,848 (6.7%)1,138/3,848 (29.6%)956/3,848 (24.8%)2,446/3,848 (63.6%)1,520/3,848 (39.5%)141/3,848 (3.7%)	65.0 (58.5-71.9)2,513/8,133 (30.9%)481/8,133 (5.9%)1,683/8,133 (20.7%)688/8,133 (8.5%)1,900/8,133 (23.4%)1,914/8,133 (23.5%)5,093/8,133 (62.6%)5,737/8,133 (70.5%)2,013/8,133 (24.8%)549/8,133 (6.8%)2,381/8,133 (29.3%)2,039/8,133 (25.1%) 5,328/8,133 (65.5%)3,306/8,133 (40.7%)397/8,133 (4.9%)	-----------------	0.510.710.090.530.360.990.990.040.410.150.970.040.230.003
Rosende 2015	Age Female	60.7550/2,326 (23.7%)	60.61,959/8,188 (23.9%)	--	--
Ryan 2005	AgeFemaleWhite raceHistory of CADHypertensionDiabetesSmokingHypercholesterolemiaPrior CABGRenal insufficiencyPursuit risk score ≥3ST depressionPositive cardiac markersAspirinβ-blockerClopidogrelUnfractionated heparinLMWHGlycoprotein IIb/IIIa inhibitorCatheterizationPCICABG	68 (56-78)4,300/10,804 (39.8%)8,751/10,804 (81.0%)3,911/10,804 (36.2%)7,498/10,804 (69.4%)3,490/10,804 (32.3%)3,004/10,804 (27.8%)5,154/10,804 (47.7%)2,334/10,804 (21.6%)1,394/10,804 (12.9%)5,229/10,804 (48.4%)4,278/10,804 (39.6%)9,778/10,804 (90.5%)9,940/10,804 (92.0%)8,524/10,804 (78.9%)4,278/10,804 (39.6%)5,564/10,804 (51.5%)4,278/10,804 (39.6%)3,771/10,804 (34.9%)7,692/10,804 (71.2%)1,394/10,804 (12.9%)1,448/10,804 (13.4%)	67 (56-77)17,764/45,548 (39.0%)36,858/45,548 (80.9%)16,898/45,548 (37.1%)31,337/45,548 (68.8%)14,621/45,548 (32.1%)12,981/45,548 (28.5%)22,136/45,548 (48.6%)9,337/45,548 (20.5%)5,967/45,548 (13.1%)21,271/45,548 (46.7%)18,174/45,548 (39.9%)40,219/45,548 (88.3%)41,813/45,548 (91.8%)35,664/45,538 (78.3%)19,722/45,538 (43.3%)24,186/45,538 (53.1%)16,671/45,538 (36.6%)17,445/45,538 (38.3%)33,250/45,548 (73.0%)19,130/45,548 (42.0%)6,103/45,548 (13.4%)	----------------------	----------------------
Turin 2009	-	-	-	-	-






